Central Vascular Access Device Market

Central venous/vascular access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream. Venous access devices that can be implanted under the skin were introduced in 1982. They allow medications to be delivered directly into larger veins, are less likely to clot, and can be left in for long periods. The CVAD may contain one or two tubes. When a CVAD contains two tubes, it is called a double or dual lumen catheter and may also be used for injecting contrast for CT or MRI scans (depending on type of CVAD).

Central Vascular Access Device Market contains market size and forecasts of Central Vascular Access Device in global, including the following market information:

Global Central Vascular Access Device Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Central Vascular Access Device Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Central Vascular Access Device companies in 2021 (%)

The global Central Vascular Access Device market was valued at 2153.6 million in 2021 and is projected to reach US$ 3327.3 million by 2028, at a CAGR of 6.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

PICC Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Central Vascular Access Device include Becton Dickinson, C. R. Bard, Inc., Smiths Medical, Inc, Teleflex Incorporated, B.Braun, NIPRO Medical Corporation, Edwards Lifesciences Corporation, Terumo Corporation and Vygon Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Central Vascular Access Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Central Vascular Access Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Central Vascular Access Device Market Segment Percentages, by Type, 2021 (%)

• PICC
• Centrally Inserted Catheters
• Implanted Ports
• Other

Global Central Vascular Access Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Central Vascular Access Device Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Non-Hospital

Global Central Vascular Access Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Central Vascular Access Device Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Central Vascular Access Device revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Central Vascular Access Device revenues share in global market, 2021 (%)
• Key companies Central Vascular Access Device sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Central Vascular Access Device sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Becton Dickinson
• C. R. Bard, Inc.
• Smiths Medical, Inc
• Teleflex Incorporated
• B.Braun
• NIPRO Medical Corporation
• Edwards Lifesciences Corporation
• Terumo Corporation
• Vygon Ltd.
• Ameco Medical
• AngioDynamics
• Romsons
• PRODIMED